Coupons, PBM's ... oh my!
Over the past few years, my coverage of coupon-generating websites/apps has increased by a lot in this blog because those have emerged as a critical way for patients to get prescriptions at lower, PBM-negotiated prices even if they have yet to satisfy an annual insurance deductible or they have no insurance at all. In general, coupon-generating websites/apps offer consumers access to the deeper pharmacy benefits manager ( " PBM " )-negotiated prices on prescription drugs, at prices which are often substantially less than the prices you could otherwise attain as a consumer without the benefit of a commercial healthcare...
Source: Scott's Web Log - September 1, 2021 Category: Endocrinology Tags: CGM CGMS coupon-generating websites apps Dexcom insulin Libre PBM test strips Source Type: blogs
Coupons, PBM's ... oh my!
Over the past few years, my coverage of coupon-generating websites/apps has increased by a lot in this blog because those have emerged as a critical way for patients to get prescriptions at lower, PBM-negotiated prices even if they have yet to satisfy an annual insurance deductible or they have no insurance at all. In general, coupon-generating websites/apps offer consumers access to the deeper pharmacy benefits manager ( " PBM " )-negotiated prices on prescription drugs, at prices which are often substantially less than the prices you could otherwise attain as a consumer without the benefit of a commercial healthcare...
Source: Scott's Web Log - September 1, 2021 Category: Endocrinology Tags: CGM CGMS coupon-generating websites apps Dexcom insulin Libre PBM test strips Source Type: blogs
More Analysts on Wall Street are Starting to Believe Dexcom's Stock is Now Fully Valued
So, on August 18, 2021, the crowd-sourced content service for financial markets known as SeekingAlpha.com, which often contains archived investor presentations and earnings transcripts from publicly-held companies, issued not one but TWO (2) slight warnings about Dexcom stock. Links to those two articles are listed below:https://seekingalpha.com/article/4450293-dexcom-too-expensive-considering-the-prospects AND https://seekingalpha.com/article/4450338-dexcom-future-sales-moderate-expectations Dexcom was the first mover into the market for continuous glucose monitors (CGMs), at least in the U.S. But Dexcom is...
Source: Scott's Web Log - August 19, 2021 Category: Endocrinology Tags: Abbott ADA Scientific Sessions CGM Dexcom GCMS Libre sensor Type 1 Type 2 Source Type: blogs
More Analysts on Wall Street are Starting to Believe Dexcom's Stock is Now Fully Valued
So, on August 18, 2021, the crowd-sourced content service for financial markets known as SeekingAlpha.com, which often contains archived investor presentations and earnings transcripts from publicly-held companies, issued not one but TWO (2) slight warnings about Dexcom stock. Links to those two articles are listed below:https://seekingalpha.com/article/4450293-dexcom-too-expensive-considering-the-prospects AND https://seekingalpha.com/article/4450338-dexcom-future-sales-moderate-expectations Dexcom was the first mover into the market for continuous glucose monitors (CGMs), at least in the U.S. But Dexcom is...
Source: Scott's Web Log - August 19, 2021 Category: Endocrinology Tags: Abbott ADA Scientific Sessions CGM Dexcom GCMS Libre sensor Type 1 Type 2 Source Type: blogs
Srs with T1D; Medicare + Lack of Good Enrollment Info from Diabetes Nonprofits
Not long ago, my friend Riva Greenberg wrote a compelling diabetes blog post which actually ran on Diabetes Minehttps://www.healthline.com/diabetesmine/nearly-50-years-with-type-1-diabetes-a-long-haulers-report although she also posted news of it on her own personal bloghttps://diabetesstories.com/2021/06/16/the-untold-story-49-years-of-type-1-diabetes/.Riva, like me, is today considered a T1D " Long Hauler " . She is now in her 49th year of living with Type 1 diabetes, meaning she ' ll soon be eligible for a Joslin 50 year medal if she chooses to claim it. I think Riva and my older sister share a common diagnosis year (I ...
Source: Scott's Web Log - August 8, 2021 Category: Endocrinology Tags: Abbott CGM CMS Dexcom Eversense FDA Freestyle Libre Medicare Seniors Senseonics Source Type: blogs
Srs with T1D; Medicare + Lack of Good Enrollment Info from Diabetes Nonprofits
Not long ago, my friend Riva Greenberg wrote a compelling diabetes blog post which actually ran on Diabetes Minehttps://www.healthline.com/diabetesmine/nearly-50-years-with-type-1-diabetes-a-long-haulers-report although she also posted news of it on her own personal bloghttps://diabetesstories.com/2021/06/16/the-untold-story-49-years-of-type-1-diabetes/.Riva, like me, is today considered a T1D " Long Hauler " . She is now in her 49th year of living with Type 1 diabetes, meaning she ' ll soon be eligible for a Joslin 50 year medal if she chooses to claim it. I think Riva and my older sister share a common diagnosis year (I ...
Source: Scott's Web Log - August 8, 2021 Category: Endocrinology Tags: Abbott CGM CMS Dexcom Eversense FDA Freestyle Libre Medicare Seniors Senseonics Source Type: blogs
Making Sense of the Novo Nordisk-Walmart Partnership to Sell Some Discounted Insulin Analogues
On June 29, 2021, Walmart Inc. and the American business unit of Novo Nordisk A/S (which is based just outside of Princeton, New Jersey known as Novo Nordisk Inc.) dropped what was intended to be a news bombshell coming just as the ADA Scientific Sessions was coming to a close. In fact, the insulin makers had hardly any big news coming from the ADA Scientific Sessions themselves this year or for the past several years (about the biggest news was from 2018 when, Novo Nordiskacquired a UK-based company known as Ziylo to use its technology to try and develop glucose-responsive insulin, but that still has a long whil...
Source: Scott's Web Log - July 15, 2021 Category: Endocrinology Tags: Aspart Novo Nordisk Novolog Walmart Source Type: blogs
Making Sense of the Novo Nordisk-Walmart Partnership to Sell Some Discounted Insulin Analogues
On June 29, 2021, Walmart Inc. and the American business unit of Novo Nordisk A/S (which is based just outside of Princeton, New Jersey known as Novo Nordisk Inc.) dropped what was intended to be a news bombshell coming just as the ADA Scientific Sessions was coming to a close. In fact, the insulin makers had hardly any big news coming from the ADA Scientific Sessions themselves this year (in fact, Novo Nordiskacquired a UK-based company known as Ziylo in 2018 to use its technology to try and develop glucose-responsive insulin, but it still has a long while before it is ready for commercialization ... if ever), becaus...
Source: Scott's Web Log - July 15, 2021 Category: Endocrinology Tags: Aspart Novo Nordisk Novolog Walmart Source Type: blogs
Reports of the Death of Diamyd's T1D Intervention Have Been Greatly Exaggerated
RememberDiamyd Medical? I wrote about the company and even interviewed one of the company execs (Peter Zerhouni, who was then Director of Business Development) back in 2010 (see that post athttps://blog.sstrumello.com/2010/05/interview-with-diamyd-medical-ab.html). A year later, I wrote another post about it not being dead yet (seehttps://blog.sstrumello.com/2011/06/teplizumab-and-dpt-1-not-dead-yet.html), but it later appeared to actually be dead, and I basically lost interest.As it turns out, the Swedish biotech firm known as Diamyd Medical isn ' t dead after all! Diamyd Medical was founded by the Swedish entrepren...
Source: Scott's Web Log - June 14, 2021 Category: Endocrinology Source Type: blogs
Reports of the Death of Diamyd's T1D Intervention Have Been Greatly Exaggerated
Remember Diamyd Medical? I wrote about the company and even interviewed one of the company execs (Peter Zerhouni, who was then Director of Business Development) back in 2010 (see that post athttps://blog.sstrumello.com/2010/05/interview-with-diamyd-medical-ab.html). A year later, I wrote another post about it not being dead yet (seehttps://blog.sstrumello.com/2011/06/teplizumab-and-dpt-1-not-dead-yet.html), but it later appeared to actually be dead, and I basically lost interest.As it turns out, the Swedish biotech firm known as Diamyd Medical isn ' t dead after all! Diamyd Medical was founded by the Swedish entrepre...
Source: Scott's Web Log - June 14, 2021 Category: Endocrinology Source Type: blogs
Should I Say Adios to Dexcom G7, Hello Abbott Freestyle Libre 2? Maybe.
ConclusionIn the end, I ' m getting sick of Dexcom and its product and being considered a market tied to Dexcom itself. I feel as if the company ' s initial focus on patients has declined, and the company now takes its T1D patients for granted as it pushes for events to drive its share price up, targets the T2D universe to generate more sales. While its retail model has made getting the product to consumers vastly easier for patients, but its basic product has really not improved much. The new G7 model will make some modest changes, along with reducing the number of SKU ' s needed for the company to commercialize the produ...
Source: Scott's Web Log - June 7, 2021 Category: Endocrinology Tags: Abbott CGM CGMS continuous glucose monitor Dexcom Freestyle Libre Source Type: blogs
Should I Say Adios to Dexcom G7, Hello Abbott Freestyle Libre 2? Maybe.
ConclusionIn the end, I ' m getting sick of Dexcom and its product. I feel as if the company ' s initial focus on patients has declined, and the company now takes its patients for granted as it pushes for events to drive its share price up, and while its retail model has made getting the product to consumers vastly easier, but its basic product has not improved much. The new G7 model will make some modest changes, along with reducing the number of SKU ' s needed for the company to commercialize the product, which is less of a patient benefit and more about making distribution to retail pharmacies easier for the company. Th...
Source: Scott's Web Log - June 7, 2021 Category: Endocrinology Tags: Abbott CGM CGMS continuous glucose monitor Dexcom Freestyle Libre Source Type: blogs
GoodRx Upends Healthcare Price Obfuscation
As Dr. Elisabeth Rosenthal told NPR in 2017 (listen to or read the interview athttps://n.pr/2OgsDMt -- it was fascinating), Americans are told over and over again that they need to be good consumers of healthcare services. But she explained that in order to be a good consumer, you need to know a price. Healthcare in the U.S. is one of the few markets in which no one can tell the consumer what the prices for their services actually are. (And she added " P.S., a lot of medicine isn ' t so elective. Your doctor says hey, you need to have your hip replaced. Or your doctor says, I ' m going to fill out a requisition for t...
Source: Scott's Web Log - March 8, 2021 Category: Endocrinology Tags: 2021 GoodRx insulin Source Type: blogs
GoodRx Upends Healthcare Price Obfuscation
As Dr. Elisabeth Rosenthal told NPR in 2017 (listen to or read the interview athttps://n.pr/2OgsDMt -- it was fascinating), Americans are told over and over again that they need to be good consumers of healthcare services. But she explained that in order to be a good consumer, you need to know a price. Healthcare in the U.S. is one of the few markets in which no one can tell the consumer what the prices for their services actually are. (And she added " P.S., a lot of medicine isn ' t so elective. Your doctor says hey, you need to have your hip replaced. Or your doctor says, I ' m going to fill out a requisition for t...
Source: Scott's Web Log - March 8, 2021 Category: Endocrinology Tags: 2021 GoodRx insulin Source Type: blogs
How to Navigate Life with a Chronic Disease Like T1D and High-Deductible Insurance Plans
Conclusion:So, this is a method to survive a high-deductible insurance plan without breaking the bank. I have done it, so I know it works. Keep in mind: insurance companies feel entitled to screw patients (you are not their customer, your employer is). Don ' t let them do it to you! (Source: Scott's Web Log)
Source: Scott's Web Log - February 8, 2021 Category: Endocrinology Tags: 2021 high-deductible insurance plans insulin rebates test strips Source Type: blogs
